Amendment Letter
Exhibit 24
Cellular Biomedicine Group, Inc.
000 Xxxxx Xxxxxxx, Xxxxx 00
Xxxxxxxxxxxx, XX 00000 XXX
Attention: Xxxxxx Xxxx
August 11, 2020
Amendment Letter
Dear Sirs,
| 1. | We, Xxxxxx Capital Limited, a company incorporated under the laws of the British Virgin Islands (the “Lender”), refer to: |
| (a) | a US$16,000,000 bridge loan agreement dated January 28, 2020 entered into between Cellular Biomedicine Group, Inc. as borrower (the “Borrower”) and the Lender (the “Loan Agreement”); and |
| (b) | a convertible promissory note issued by CBMG in favor of the Lender pursuant to the terms of the Loan Agreement, dated January 30, 2020 (the “Promissory Note”). |
| 2. | Unless otherwise defined in this Letter, words and expressions defined in the Loan Agreement shall have the same meanings when used in this Letter. |
| 3. | Pursuant to Section 5.7 (Amendment) of the Loan Agreement and Clause 9 (Modification; Waiver) of the Promissory Note, with effect from the date hereof: |
| (a) | Loan Agreement: the following paragraph shall be inserted as Section 1.4 into the Loan Agreement: |
“Notwithstanding anything to the contrary contained in this Agreement, each tranche of the Loan under this Agreement shall only become due and payable on the earlier of (i) August 7, 2021, and (ii) the occurrence of an Event of Default (as defined in the Note) for so long as such Event of Default has not been remedied by the end of the applicable grace period as set out in Section 6 of the Note.”
| (b) | Promissory Note: the definition of “Maturity Date” in the Promissory Note shall be amended and restated as follows: |
“Maturity Date” means the earlier of:
| (i) | August 7, 2021; and |
| (ii) | the occurrence of an Event of Default (as described in Section 6 below) for so long as such Event
of Default has not been remedied by the end of the applicable grace period as set out in Section 6. |
| 4. | Save as amended by this Letter, the provisions of the Loan Agreement and the Promissory Note shall continue in full force and effect. |
| 5. | References in the Loan Agreement to “this Agreement” and references in the Promissory Note to “this Note” shall, unless the context otherwise requires, be construed as references to the Loan Agreement and the Promissory Note as amended by this Letter, respectively. |
| 6. | The provisions of Section 5 (Miscellaneous) of the Loan Agreement, except Section 5.2 (Entire Agreement), shall be deemed to be incorporated in this Letter in full, mutatis mutandis. |
[Signature page follows]
2
Please sign, date and return the enclosed copy of this Letter to signify your acceptance and acknowledgement of its terms and conditions.
| Yours truly, | |
| XXXXXX CAPITAL LIMITED | |
| as Lender | |
| /s/ Xxxx Xx | |
| Name: Xxxx Xx | |
| Title: Director | |
[Signature Page to Amendment Letter]
| Agreed and accepted: | |
| CELLULAR BIOMEDICINE GROUP, INC. | |
| as Borrower | |
| /s/ Xxxxxx Xxxx | |
| Name: Xxxxxx Xxxx | |
| Title: Chief Legal Officer |
[Signature Page to Amendment Letter]
